Environmental Cardiology: Getting to the Heart of the Matter by Weinhold, Bob
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Cardiovascular disease (CVD) is the lead-
ing killer in many developed countries,
and is soon expected to be the leading
killer in all countries. A number of factors
have raised CVD to this unsavory stature,
among them lack of exercise, poor diet,
and smoking. But evidence has slowly
been building to indicate that exposures
to chemicals and other environmental
substances also can have a profound
impact on heart health. The link between
environmental agents and CVD was once
considered tenuous by much of the med-
ical and scientific establishment. But after
watching the evidence accumulate over
the years, with a surge in the past five
years, more and more scientists, doctors,
and organizations are acknowledging the
importance of a field that some are calling
environmental cardiology.
One group that is beginning to embrace
environmental cardiology is the American
Heart Association (AHA), an 80-year-old
organization that has traditionally focused
on risk factors such as poor diet and lack
of exercise as some of the most important
contributors to CVD. In the 1 June 2004
issue of Circulation, an expert panel of 11
researchers and physicians published an
AHA Scientific Statement that concluded
that air pollutants, one of the major envi-
ronmental exposure sources under investi-
gation by environmental cardiologists,
pose a “serious public health problem” for
CVD. This is the first official AHA
acknowledgment of such links.
The group’s decision was based on the
breadth and depth of the accumulating
information. “There was no single major
study that prompted the writing of this
paper,” says Sidney Smith, past president
of the AHA and a professor of medicine at
the University of North Carolina at Chapel
Hill. “It was the gathering body of evi-
dence that connected air pollution with
cardiovascular diseases, extending well
beyond cigarette smoke.”
The AHA paper was a very positive
development in the eyes of some of the
researchers who have been involved in
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Focus | Environmental Cardiologythe field for many years. “That’s pretty
amazing,” says C. Arden Pope III, an envi-
ronmental epidemiologist at Brigham
Young University. “It’s taken the research
out of the fringes and made it part of the
mainstream.”
Less than two months after the release of
the AHA statement, the U.S. Environ-
mental Protection Agency (EPA) gave a clue
to how seriously it takes this issue, awarding
the largest scientific research grant in its his-
tory, $30 million, to study links between air
pollution and CVD. The research team will
be headed by associate environmental and
occupational health professor Joel Kaufman
of the University of Washington, and
includes scientists from nine other universi-
ties and medical centers. 
A few other government agencies, such
as the National Heart, Lung, and Blood
Institute (NHLBI), have also begun to
address the links between environmental
agents and CVD, as have advocacy organi-
zations such as the American Lung
Association and the Natural Resources
Defense Council. And the NIEHS, one of
the original players in the environmental
cardiology arena, has ramped up its efforts
to explore this area of research.
There is still a ways to go before environ-
mental cardiology is fully embraced as a med-
ical paradigm. Many major public health
organizations, such as the World Health
Organization (WHO) and the Centers for
Disease Control and Prevention (CDC),
have yet to fold this concept into their pre-
vention efforts in any significant way. And
there is very little trickle-down into the typi-
cal doctor–patient relationship.
Nonetheless, environmen-
tal cardiology shows signs of
increasingly becoming a fac-
tor in research, public policy
discussion, and pollutant reg-
ulation, as its presence spreads
into journals, conferences,
textbooks, e-mail discussion
groups, and continuing med-
ical education courses. Even
The Weather Channel is get-
ting into the act with a new
feature that advises viewers on
daily levels of pollutants that
can affect heart health.
A Heavy Burden for
Hearts Worldwide
The most basic facts about
CVD haven’t been available
for very long. The early
decades of the 1900s, when
physicians were just beginning
to form groups to address
heart diseases, were a time of
“almost unbelievable ignorance” about these
conditions, according to the AHA website. 
That has changed, spurred in large part
by the huge impact CVD has on people.
Heart conditions such as heart attack and
congestive heart failure are the leading
killer in the United States, and stroke is
third, according to the CDC’s Deaths:
Preliminary Data for 2002, released in
February 2004. Combined, these two cate-
gories of CVD alone account for about
35% of all U.S. deaths, compared to 23%
for cancers. Other serious health problems
that fall into the CVD classification
include aortic aneurysms, high blood pres-
sure, and congenital cardiovascular defects.
CVD deaths had been declining sharply
in the United States over the past few
decades, but that curve has flattened out in
recent years. Death rates for heart diseases
(responsible for nearly 696,000 U.S. deaths
in 2002) declined about 3% from 2001 to
2002, as did death rates for stroke (respon-
sible for about 163,000 U.S. deaths in
2002). But death rates attributed to high
blood pressure (responsible for about
20,000 U.S. deaths in 2002) rose about
3%, continuing a steady rise over the prior
20 years. 
Other industrialized nations have seen
similar patterns. The WHO says that CVD
accounts for about one-third of global
deaths, killing about 16.7 million people
each year. Patterns in developing countries
are quickly emulating those in developed
countries, thanks to the imported western
lifestyle and reductions in infectious disease
deaths and other acute causes of death. The
WHO estimates that CVD will be the lead-
ing killer in developing countries by 2010.
But there are huge variations from
country to country. In 36 countries tracked
by the AHA, CVD death rates differ dra-
matically, with rates in some of the most-
affected countries, such as the Russian
Federation, Bulgaria, and Romania, more
than five times higher than in some of the
least-affected countries, such as France,
Japan, and Australia. Variations in factors
such as diet, exercise, smoking, health care
quality and availability, and pollution like-
ly play a role in these differences.
Within a country, there also can be
huge variations. In the United States, the
CVD rate in the least-affected state,
Minnesota, is less than 60% the rate in the
most-affected state, Mississippi, according
to the AHA’s Heart Disease and Stroke
Statistics—2004 Update. And the gap has
been widening. Minnesota had a 27%
decline from 1990 to 2000, while
Mississippi saw a 12% decline. 
Race and ethnicity are significant risk
determinants. Black women in the United
States are 2.5 times as likely as Asian and
Pacific Islander women to die of diseases of
the heart, and a similar ratio of 2.25 to 1
holds for black men, according to CDC
statistics published in Women and Heart
Disease and Men and Heart Disease. Death
rates for American Indian, Alaska Native,
Hispanic, and white men and women fall
in between these two extremes. 
Similar disparities exist for stroke, with
the death rate for black men and women
more than twice that of the least-affected
groups—Hispanics, Amer-
ican Indians, and Alaska
Natives—according to the
CDC’s 2003 publication
Atlas of Stroke Mortality:
Racial, Ethnic, and Geo-
graphic Disparities in the
United States. 
The elderly tend to be
most vulnerable to CVD,
and the problem is expected
to worsen in many countries
as populations age. But sud-
den cardiac-related deaths
have increased dramatically
among people under age 35,
according to the CDC’s 2003
report A Public Health Action
Plan to Prevent Heart Disease
and Stroke. And CVD is the
third-leading cause of death
for children under 15,
according to the AHA. 
Deaths aren’t the only
consideration. Chronic dis-
eases, which the CDC says
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Leading Causes of Death for All Males and Females
United States,2001
A Total CVD D Chronic Lower Respiratory Diseases
B Cancer E Diabetes Mellitus
C Accidents F Alzheimer Disease
Source: AHA.Heart Disease and Stroke Statistics—2004 Update.Dallas,TX:American Heart Association;2003.
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affect more than 90 million people in the
United States alone, are often due to CVD.
Diseases of the heart, high blood pressure,
and stroke underlie about one of every five
U.S. chronic disease cases.
CVD also includes cardiac birth
defects. Among structural birth defects,
cardiovascular malformations are the most
common among live births, affecting 1
baby in 125, according to the March of
Dimes. They are also the leading cause of
birth defect–related infant deaths.
There is also growing evidence that pre-
natal exposures to some environmental pol-
lutants, such as solvents, pesticides, and
dioxins, may result in subtle functional
abnormalities that show up as disease in
adulthood. In the area of CVD, this
hypothesis—although important—is only
just beginning to receive much attention. 
The Role of the Environment: A
Change of Heart
Until the past few years, the huge world-
wide toll of CVD had been attributed pri-
marily to lifestyle factors such as poor diet,
lack of exercise, lack of medical care, smok-
ing, and exposure to secondhand smoke. A
large worldwide study published 11
September 2004 in The Lancet found that
nine lifestyle and biological factors
accounted for 90% of the risk for one
major form of CVD, heart attack, with two
factors—cigarette smoking and an abnor-
mal ratio of blood lipids—accounting for
two-thirds of that risk. 
But public health officials still haven’t
been able to explain the cause behind a sig-
nificant number of CVD deaths, says Aruni
Bhatnagar, a professor of medicine and
project leader of the University of Louis-
ville’s Center of Environmental Cardiol-
ogy, in a February 2004 article in the
American Journal of Physiology—Heart and
Circulatory Physiology.
Clues about environmental influences
began to show up decades ago. For
instance, beer containing elevated concen-
trations of cobalt (used for quite a few years
around the world to retain the beer’s head)
were found in the 1960s to contribute to
cardiomyopathy in some drinkers. Studies
by the National Toxicology Program have
examined links between numerous envi-
ronmental agents and cardiovascular effects
for several decades, says NIEHS chemist
June Dunnick. And a 1985 study of chain
saw exhaust published in the European
Journal of Respiratory Diseases found an
increase in carboxyhemoglobin, which
makes it harder for the blood to carry oxy-
gen and can lead to serious nerve damage. 
By 1994, a number of published studies
had found links between smoking and
CVD. Evidence against smoking and sec-
ondhand smoke continues to grow, and
among the chemical exposures with poten-
tial CVD links, tobacco smoke is the most
worrisome so far, says William Farland, act-
ing deputy assistant administrator for sci-
ence in the EPA Office of Research and
Development. 
A few researchers saw some of these
early clues about various chemicals and
shifted their work into the environmental
realm. Eliseo Guallar, an assistant professor
of epidemiology at The Johns Hopkins
University, studied nutritional aspects of
fish oils for several years, but saw no con-
clusive evidence of benefits. Then he saw a
study on mercury in fish, and the light
went on. “For a long time, it never
occurred to me that, when you eat fish, you
eat contaminants,” he said. “I read this and
I said, ‘Of course!’” He shifted his research,
and published a study in the 28 November
2002 New England Journal of Medicine that
found that mercury canceled out the bene-
fits of fish oils and contributed to an
increased risk of heart attack. 
Others were following a parallel path. In
2000, University of Louisville researchers
coined the term “environmental cardiolo-
gy,” Bhatnagar says, and established the
Center of Environmental Cardiology in the
university’s Health Sciences Center. Wayne
Cascio, chief of the Division of Cardiology
at East Carolina University’s Brody School
of Medicine, says he came up with the same
term of “environmental cardiology” on his
own, and Harvard’s John Godleski, an asso-
ciate professor of environmental health who
has published eight related papers in recent
years, uses the term as well. 
Others, such as Farland, have heard the
term and think it’s appropriate, especially
for bringing cardiologists into the field, but
aren’t using it routinely. Thomas Burke, a
professor of health policy and management
at the Johns Hopkins Bloomberg School of
Public Health, uses a long version, “envi-
ronmental influences on cardiovascular
health,” but likes “environmental cardiolo-
gy.” Guallar thinks the term “cardiology” is
a little too clinically oriented, and uses the
term “cardiovascular disease epidemiology.”
Whatever term is used, by 2002 the
notion of environmental cardiology was no
longer considered outlandish after other
epidemiological studies, and some studies
of biological processes, found numerous
links between different chemicals and
CVD. That year, the NIEHS, the EPA,
NHLBI, the AHA, and St. Jude Medical
convened a workshop in Durham, North
Carolina, and scores of participants dis-
cussed the links between environmental
agents and CVD. Environmental cardiolo-
gy even began to creep into the public con-
sciousness with the Food and Drug
Administration’s 2004 ban of dietary sup-
plements containing ephedrine alkaloids,
based on evidence that the substances are
linked to heart attack and stroke.
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Smoking gun. In study after study, tobacco
smoke is one of the pollutants most directly
linked with CVD.
Chemicals and cardiology. Research studies
have linked certain pesticides with CVD, includ-
ing some effects in children.Fingering the Villains 
Given the evidence so far, fine particulates
appear to be one of the primary environ-
mental villains linked with CVD, and are
drawing much of the research interest. One
of the first major developments was publi-
cation of findings from the Six Cities Study
in the 9 December 1993 New England
Journal of Medicine. The study, by Harvard
environmental epidemiologist Douglas
Dockery, Pope, and six others, found a sig-
nificant link between ambient urban air
pollution, especially fine particulates, and
increased deaths caused by cardiopul-
monary disease, along with increases in
lung cancer. In January 2004, Circulation
published a study by Pope and others cov-
ering more than half a million people over
16 years, which found that fine particulates
were more strongly linked with deaths
from cardiovascular causes than with
deaths from respiratory causes. The pattern
of cardiovascular deaths was consistent
with evidence that mechanistic pathways
linking exposure and death included pul-
monary and systemic inflammation, accel-
erated atherosclerosis (hardening of the
arteries), and changes in cardiac autonom-
ic function (as measured by changes in
heart rate variability).
In addition to particulates, dozens of
other substances have been identified as
playing some role in CVD. The other five
EPA “criteria” air pollutants (ozone, carbon
monoxide, nitrogen oxides, sulfur dioxide,
and lead) have some evidence linking them
with CVD, as do at least 17 of the 87
drinking water contaminants monitored
by the EPA. At least 8 of the 116 contam-
inants in people tracked so far in the
CDC’s ongoing biomonitoring project
have CVD links. Pat Mastin, chief of the
NIEHS Cellular, Organ, and Systems
Pathobiology Branch, points out that sev-
eral occupational exposures also have been
associated with CVD, including exposures
to vinyl chloride (used to produce
polyvinyl chloride and industrial solvents),
carbon monoxide (a common exhaust gas),
and allylamine (used in ion exchange
resins, pharmaceuticals, and water-soluble
polymers). 
According to Mastin, arsenic has been
linked in Asia with a condition known as
black foot disease, so named because of the
gangrene caused by severe disease in the
blood vessels. In addition, he says, areas of
the United States have high drinking water
concentrations of arsenic, and there is evi-
dence for a link between arsenic exposure
and ischemic heart disease and hyperten-
sion in such areas. And there are more than
50 other substances, including many heavy
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Note: Rates adjusted to the European Standard population.International Classification of Diseases,Ninth Revision codes are 390–459 for cardiovascular disease,
410–414 for coronary heart disease,and 430–438 for stroke.Countries using International Classification of Diseases,Tenth Revision (ICD/10) are noted with *.
ICD/10 codes are I00–I99 for cardiovascular disease,I20–I25 for coronary heart disease,and I60–I69 for stroke.
Source:The American Heart Association Statistical Fact Sheet,http://www.americanheart.org/downloadable/heart/1077185395308FS06INT4(ebook).pdf.
Death Rates for Total Cardiovascular Disease,Coronary Heart Disease,
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metals, solvents, and a few pesticides, that
have been implicated in CVD by other
sources.
The research conducted so far has found
many tangible indicators of cardiovascular
system effects, including atherosclerosis;
vasoconstriction; and changes in heart rate
variability, blood pressure, coagulation,
platelet activation, endothelial cells, and the
clotting protein fibrinogen. Those changes
have been linked with serious outcomes
such as ischemic heart disease, congestive
heart failure, acute myocardial infarction,
malignant ventricular arrhythmias, plaque
vulnerability, acute thrombosis, stroke, and
hypertension.
The difficult job of figuring out exact-
ly how various chemicals cause these prob-
lems has just begun. Many pathways are
under investigation. On the top of the list
for some is the systemic inflammation
caused by some chemicals. “In the end, it’s
all going to be tied to inflammation,”
Cascio says.
Pope, who agrees inflammation is a key
element, has another prime suspect.
“There’s simply a lot of evidence that there’s
a role for [effects on] autonomic function,”
he says. 
Cellular changes, such as alterations in
ion channel function, cell proliferation, sig-
nal transduction pathways, and cell signal-
ing, also are under scrutiny. For instance,
research by Armando Meyer and colleagues
published in the February 2004 EHP
found that the insecticide chlorpyrifos
affects cell signaling cascades critical to car-
diac homeostasis.
Problems may be caused not just by a
chemical, but by its metabolites. In a study
reported in the September 2004 issue of
Toxicological Sciences, Dunnick and
NIEHS colleague Abraham Nyska found
that bis(2-chloroethoxy)methane caused
mitochondrial damage in hearts in a
rodent model system. They hypothesized
that the thiodiglycolic acid, a metabolite of
bis(2-chloroethoxy)methane as well as
many other chemicals, causes this chemi-
cal-related mitochondrial damage and
heart toxicity. Dunnick and Nyska
observed a biphasic response: initial dam-
age to myocytes was repaired in an appar-
ent temporary adaptive response that the
animals were no longer able to launch as
they aged. 
Other areas of concern include genetic
variations and expression, gene polymor-
phisms, oxidative stress, protein expression,
and post-translational modifications. In
addition, many researchers suspect indirect
links with the immune, pulmonary, and
neurological systems.
Seeking the Heart of the Matter
Millions of dollars are being pumped into
environmental cardiology
research. The largest single
award is the $30 million
granted in July 2004 to the
University of Washington–led
team, which will focus on the
effects of fine particulates.
The 10-year study will evalu-
ate about 8,700 people in six
states, representing a variety of
ethnic groups, for clinical and
subclinical effects such as
heart attack, stroke, and ather-
osclerosis.
The University of Louis-
ville Center of Environmental
Cardiology was awarded a
five-year $7 million NIEHS
grant in 2003 for studies on
the effects of aldehydes, which
are found throughout the
environment, making up a
large part of typical urban air
pollution and also showing up
in food and drinking water.
The NIEHS also awarded $3
million in 2003 to environ-
mental epidemiologist Ralph
Delfino at the University of
California, Irvine, and his col-
leagues to study the effects of
fine particulates in the elderly.
The study, expected to con-
clude in 2007, will investigate
a range of CVD effects, in part
through intensive personal
monitoring, and will address seasonal and
geographic variations. The EPA and the
NIEHS awarded a dozen grants in
September 2004, totaling about $4 million,
that focus on a variety of links between par-
ticulates and CVD. The topics range from
acute effects of particulates on the auto-
nomic nervous system to chronic effects of
particulates on atherosclerosis, Mastin says.
The Health Effects Institute, funded by
the EPA and industry, is backing several
related studies, says institute senior scientist
Geoffrey Sunshine. A University of
Rochester study looking at the effects of par-
ticulates on CVD is expected to be pub-
lished by November 2004. Dockery is look-
ing at whether particulate exposures may
make internal cardiac defibrillators fire more
frequently. And Annette Peters, head of the
Institute of Epidemiology at Germany’s gov-
ernment-funded GSF–National Research
Center for Environment and Health, and
her colleagues are investigating the effects of
fine particulates on nonfatal myocardial
infarction. Many other related studies are
being conducted around the world.
Karen Kuehl, a professor of pediatrics
and a cardiologist at Children’s National
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Particularly offensive. Fine particulate air pollution is being
investigated as a contributor to effects such as heart attack,
stroke,and atherosclerosis,especially in the elderly.
A diet for disease? New research will look at
links between CVD and chemical contami-
nants in food and water.Medical Center in Washington, D.C., has
participated in a number of studies of envi-
ronmental influences on cardiovascular
birth defects, but laments the limited fund-
ing available, possibly due to the minor
influence infants have on the budget
process. “Babies don’t vote,” she says with a
short laugh. Nonetheless, the NIEHS has
begun to make this area more of a priority,
and issued the program announcement
“Environmentally Induced Cardiovascular
Malformations” in 2002. Mastin, whose
branch administers this program, says
research funded under these grants is exam-
ining how prenatal exposures influence the
risk of cardiovascular birth defects. 
Related information may also eventual-
ly come out of the chronic disease tracking
efforts of the CDC’s Environmental Public
Health Tracking Program, says Burke, who
heads one arm of the CDC effort. The
fledgling program, begun in 2002, is
designed to eventually provide extensive
data documenting links between the pres-
ence of environmental agents, exposures,
and ensuing diseases, including CVD.
From a policy perspective, the AHA is
continuing to develop official policy on the
links between pollutants and CVD. It’s also
advocating and supporting further research
to help it determine whether pollutants
will rise to the level of an actual risk factor
in its perception, meaning that it is a sig-
nificant, independent contributing factor
to CVD. The evidence isn’t quite there yet,
according to Smith.
Although the links between chemical
exposures and CVD are becoming more
widely recognized, few public health agen-
cies have responded yet. The WHO is
focusing most of its efforts on preventing
CVD caused by factors such as diet, exer-
cise, and smoking, which it says account
for 75% of CVD, though it acknowledges
that pollutants other than cigarette smoke
are a cause for concern. In the United
States, the CDC updated its Public Health
Action Plan to Prevent Heart Disease and
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Diseases and  Total  Total  Total  Non-Hispanic Non-Hispanic Mexican
Risk Factors Population Males Females Whites Blacks Americans
Males Females Males Females Males Females
Congenital Defects
Mortality 2001 (all ages) 4.1 K 2.1 K 1.9 K 1.8 K 1.5 K 0.4 K 0.3 K — —
Mortality 2001 (< age 15) 2.1 K 1.1 K 1.0 K — — — — — —
Tobacco
Prevalence grades 9-12:
Current tobacco use 2001 — 38.5% 29.5% — — — — — —
Current cigar use 2001 — 22.1% 8.5% — — — — — —
Smokeless tobacco use 2001 — 14.8% 1.9% — — — — — —
High school students:
Used tobacco in last 30 days — — 43.4% 32.3% 21.6% 17.4% 31.5% 27.2%
Blood Cholesterol
Ages 4-19:
Mean total cholesterol mg/dL 165 — — 162 166 168 171 163 165
Ages 4-19:
Mean HDL cholesterol mg/dL — — — 48 50 55 56 51 52
Ages 12-19:
Mean LDL cholesterol mg/dL — — — 91 100 99 102 93 92
Physical Inactivity
Prevalence 2001 grades 9-12:
Vigorous activity last 7 days — — — 73.7% 59.8% 72.4% 47.8% 68.8% 52.4%
Moderate activity last 7 days — — — 29.8% 24.7% 23.7% 16.5% 25.9% 18.5%
Overweight
Prevalence 2001:
Preschool children ages 2-5 >10% — — 10% 8% 11%
Children ages 6-11 3.8 M (15.3%) 2.0 M (16.0%) 1.8 M (14.5%) 11.9% 12.0% 17.6% 22.1% 27.3% 19.6%
Adolescents ages 12-19 5.0 M (15.5%) 2.6 M (15.5%) 2.4 M (15.5%) 13.0% 12.2% 20.5% 25.7% 27.5% 19.4%
Students grades 9-12 — — — 12.4% 5.3% 17.5% 14.6% 21.3% 8.8%
Children,Youth,and Cardiovascular Disease
Note:K = thousands;M = millions;mg/dL = milligrams per deciliter;(–) = data not available.Overweight in children is body mass index (BMI) at 95th percentile of the Centers for Disease Control and Prevention 2000 growth chart.Death rates are
age-adjusted per 100,000 population,based on the 2000 U.S.standard.
Source: AHA.Heart Disease and Stroke Statistics—2004 Update.Dallas,TX:American Heart Association;2003.Environmental Health Perspectives • VOLUME 112 | NUMBER 15 | November 2004 A 887
Stroke in 2003, but the plan
still pays scant attention to
environmental contami-
nants, though it acknowl-
edges pollutants are an issue.
NHLBI, too, acknowledges
the issue of chemical expo-
sures, says George Sopko, a
cardiologist at that institute,
but has not given it much
weight yet. Few, if any, state
health programs address
environmental cardiology in
any significant way, accord-
ing to several state health
officials.
Riding the Learning
Curve
The venues for professionals
interested in learning more
about the links between
environmental agents and
CVD are expanding. One journal that
focuses extensively on related issues of car-
diovascular toxicities of drugs, novel ther-
apies, and environmental pollutants is
Cardiovascular Toxicology, which began
publishing in 2001. Among the general
journals that have published related stud-
ies are EHP,  JAMA, the New England
Journal of Medicine,  Circulation,  Inhal-
ation Toxicology,  Toxicologic Sciences,
Epidemiology, and the American Journal of
Epidemiology.
The 2004 reference book Netter’s
Cardiology has a chapter on the topic,
authored by Cascio, and the issue is
increasingly appearing on the agenda of
conferences run by organizations such as
the AHA, the American Thoracic Society,
the International Society of Environmental
Epidemiology, the NIEHS, and the EPA.
Discussions on the latest developments
routinely occur on the NIH e-mail group
EnviroHeart (http://list.nih.gov/archives/
enviroheart.html).
Interested doctors may soon be able to
learn more through continuing medical
education programs. The EPA is working
on a certification program to educate doc-
tors about ozone and respiratory effects,
says agency environmental health scientist
Susan Stone, and the agency anticipates
following that up with a program on par-
ticulates that will cover cardiovascular
effects. 
At the moment, though, doctors have
no accepted medical treatments that are
known to be effective in reducing the
effects of chemicals on CVD, says Robert
D. Brook, who is lead author of the AHA
Scientific Statement, an assistant professor
of medicine at the University of Michigan,
and a practicing physician. Instead, con-
cerned people should avoid exposures to
the extent possible, he says. 
One tool to help people avoid air pol-
lution exposures is the EPA’s AIRNow web-
site (http://www.epa.gov/airnow/), Stone
says. Daily reports on local particulate and
ozone levels can help people decide
whether to limit activity and thus, expo-
sure. That idea will be incorporated into a
Weather Channel feature called “Air
Aware” that the EPA is collaborating on,
which is scheduled for launch in mid-
autumn 2004.
The EPA also is finalizing an educa-
tional poster designed to be hung in doc-
tors’ offices and elsewhere, which is expect-
ed to be released in November 2004. It
devotes about half its space to the effects of
a few common pollutants on the cardiovas-
cular system. The other half addresses res-
piratory effects. In 2003 the agency
released an educational brochure on partic-
ulates that folded in some information on
cardiovascular effects. The brochure has
been distributed by some state and local air
agencies, and is available to the public
through the EPA’s National Center for
Environmental Publications.
Reaching a Regulatory Threshold
Given the relatively early stages of wide-
scale research into the links between chem-
icals and CVD, it likely will be some time
before any regulations change. “I wish new
science were incorporated more rapidly,
but I’m not kidding myself that the EPA is
going to hop to it on this one,” says Gina
Solomon, a senior scientist with the
Natural Resources Defense Council and a
practicing physician. 
Greg Dana, vice president
of environmental affairs with
the Alliance of Automobile
Manufacturers, hopes she is
correct. He says that vehicle
pollution, which accounts for
a large part of the environ-
mental load of particulates
and other air pollutants, has
already been addressed
enough. “There’s a pretty big
onslaught of rules and regula-
tions in coming years that will
take care of a lot of emis-
sions,” he says. “Hopefully
we’ve addressed whatever con-
cerns are being raised.”
Dana points to a number
of emissions regulations set to
phase in over the next several
years. Federal “Tier 2” regula-
tions set by the Clean Air Act
Amendments of 1990 will
phase in between 2004 and 2009, and will
reduce car and light truck emissions by
80% over today’s cars. Beginning in model
year 2007, Tier 2 regulations will reduce
heavy-duty vehicle nitrogen oxide emis-
sions by 90% and particulate emissions by
95%. Both of these rules also contain pro-
visions to remove sulfur from gasoline and
diesel fuel. In addition, “maximum achiev-
able control technology” standards are now
final for 110 industry categories covering
almost all business sectors in the country to
control air toxics. “These are three of the
biggest [rules], but there are others that will
reduce emissions even more,” Dana says.
If additional regulations are adopted,
they might address concentrations of
allowable exposure, time period of expo-
sure, and vulnerable populations, says
Farland. He notes the EPA is already incor-
porating some CVD concerns into discus-
sions about the next-generation fine partic-
ulate standard under consideration (which
will be published as a proposal by 31
March 2005 and finalized by 20 December
2005). Guallar also notes that environ-
mental cardiology research might shift
cost–benefit calculations used in assessing
new regulations. 
Although the regulatory outlook is
unpredictable, and much of the science
and medicine is in its early stages, the rap-
idly expanding evidence appears to be car-
rying the newly recognized field of envi-
ronmental cardiology into ever-widening
areas of influence. Says Pope, “It’s remark-
able what’s happened in the last five to six
years. I think we’re making a lot of
progress.”
Bob Weinhold
Focus | Environmental Cardiology
Estimated Direct and Indirect Costs of Cardiovascular Disease
and Stroke
United States,2004
Source: AHA.Heart Disease and Stroke Statistics—2004 Update.Dallas,TX:American Heart Association;2003.
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